New research sheds light on how mesothelioma develops
Mesothelioma has been a high-profile disease at the center of several multibillion-dollar lawsuits, but the disease itself remains a medical mystery.
May 10, 2023
0
66
Mesothelioma has been a high-profile disease at the center of several multibillion-dollar lawsuits, but the disease itself remains a medical mystery.
May 10, 2023
0
66
In a new study, University of California, Irvine researchers found that exposure to the compound tetrahydrocannabinol (THC, a component of cannabis) at a young age could lead to depleted ovarian follicles and matured eggs ...
Mar 21, 2023
0
146
A combination of chemotherapy and drugs that stimulate the immune system to combat cancer is increasingly used to control progression of the disease in patients. On the other hand, clinical studies show that the combination ...
Jan 30, 2023
0
39
A research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug's "high." The breakthrough ...
Nov 14, 2022
1
96
Firefighters are the heroes of our society, protecting us around the clock. But those 24-hour shifts are hard on the body and increase the risk of cardiometabolic diseases, such as heart disease and diabetes, as well as cancer. ...
Oct 4, 2022
0
71
An estimated 70% of primary care physicians reported in a survey that they would still prescribe antibiotics to treat asymptomatic infections based solely on a positive urine specimen. This is despite long-held medical guidelines ...
May 27, 2022
0
338
It's not often that a failed clinical trial leads to a scientific breakthrough.
May 4, 2022
0
715
Inhaled nanoparticles—human-made specks so minuscule they can't be seen in conventional microscopes, found in thousands of common products—can cross a natural, protective barrier that normally protects fetuses, according ...
Apr 20, 2022
0
242
A team of researchers at Atara Biotherapeutics has conducted a small Phase I clinical trial of a therapeutic called ATA188 that targets Epstein-Barr infections (EBV) as a treatment for multiple sclerosis (MS). Representatives ...
An investigation into the origins of the sensation of pain has led to the development of a novel and durable treatment for inflammatory pain that could be a promising alternative to opioids. The preclinical research was conducted ...
Oct 4, 2021
1
139